Gossamer Bio, Inc. (GOSS)
0.3545
+0.01
(+4.08%)
USD |
NASDAQ |
May 13, 16:00
0.3545
0.00 (0.00%)
After-Hours: 17:02
Gossamer Bio Total Liabilities (Quarterly) : 295.01M for Dec. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Vanda Pharmaceuticals, Inc. | 152.76M |
| Gilead Sciences, Inc. | 32.85B |
| Ironwood Pharmaceuticals, Inc. | 651.71M |
| CytomX Therapeutics, Inc. | 39.41M |
| Quince Therapeutics, Inc. | 10.95M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 172.25M |
| Shareholders Equity (Quarterly) | -122.76M |
| Debt to Equity Ratio | -1.653 |
| Current Ratio | 2.643 |
| Net Debt Paydown Yield | 0.02% |